Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Chapple

Showing results (61-70 of 271) with videos related to

Pageof 28
Sort By:
International Urogynecology Journal|November 26, 2009
A landmark in cooperationMickey M Karram, Christopher R Chapple
BJU International|March 24, 2009
Lower urinary tract symptoms: new perspectives on prevalence, burden and comorbidities. IntroductionChristopher R Chapple, Steven A Kaplan
Nature Reviews. Urology|October 22, 2014
Contemporary concepts in the aetiopathogenesis of detrusor underactivityNadir I Osman, Christopher R Chapple
European Urology Focus|April 4, 2022
Underactive Bladder Versus Bladder Outlet Obstruction: Don't Get Tricked!Christopher R Chapple, Nadir I Osman
European Urology|August 17, 2020
Is Urethrotomy as Good as Urethroplasty in Men with Recurrent Bulbar Urethral Strictures?Nadir I Osman, Christopher R Chapple
Arab Journal of Urology|November 12, 2015
Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approachesNadir I Osman, Christopher R Chapple
Current Opinion in Urology|June 8, 2015
Contemporary surgical management of female urethral stricture diseaseNadir I Osman, Christopher R Chapple
BMJ (Clinical Research Ed.)|September 9, 2006
Benign prostatic hyperplasia: treatment in primary careAnand K Patel, Christopher R Chapple
Current Opinion in Urology|June 2, 2005
Urinary diversion: a new look at the terminology?Richard Turner Warwick, Christopher R Chapple
European Urology|January 31, 2006
Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL)Martin C Michel, Christopher R Chapple
Pageof 28

Showing results (61-70 of 271) with videos related to

Sort By:
Pageof 28
International Urogynecology Journal|November 26, 2009
A landmark in cooperationMickey M Karram, Christopher R Chapple
BJU International|March 24, 2009
Lower urinary tract symptoms: new perspectives on prevalence, burden and comorbidities. IntroductionChristopher R Chapple, Steven A Kaplan
Nature Reviews. Urology|October 22, 2014
Contemporary concepts in the aetiopathogenesis of detrusor underactivityNadir I Osman, Christopher R Chapple
European Urology Focus|April 4, 2022
Underactive Bladder Versus Bladder Outlet Obstruction: Don't Get Tricked!Christopher R Chapple, Nadir I Osman
European Urology|August 17, 2020
Is Urethrotomy as Good as Urethroplasty in Men with Recurrent Bulbar Urethral Strictures?Nadir I Osman, Christopher R Chapple
Arab Journal of Urology|November 12, 2015
Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approachesNadir I Osman, Christopher R Chapple
Current Opinion in Urology|June 8, 2015
Contemporary surgical management of female urethral stricture diseaseNadir I Osman, Christopher R Chapple
BMJ (Clinical Research Ed.)|September 9, 2006
Benign prostatic hyperplasia: treatment in primary careAnand K Patel, Christopher R Chapple
Current Opinion in Urology|June 2, 2005
Urinary diversion: a new look at the terminology?Richard Turner Warwick, Christopher R Chapple
European Urology|January 31, 2006
Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL)Martin C Michel, Christopher R Chapple
Pageof 28